LumiraDx SARS-CoV-2 Antigen test granted emergency use approval in India
LumiraDx claims that its microfluidic technology and point of care platform supports a wide range of tests with…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Oct 21
LumiraDx claims that its microfluidic technology and point of care platform supports a wide range of tests with…
24 Sep 21
The acquisition will help GE Healthcare to expand its $3bn ultrasound business from diagnostics into the surgical space
02 Sep 21
Thermo Fisher said that NGS-based CDx are widely used to match patients with new treatments for cancer and…
19 Aug 21
Roche’s VENTANA MMR RxDx Panel is said to be the first companion diagnostic test to identify patients with…
12 Aug 21
The two-gene, single-well test has been designed using a database of more than 1,000,000 sequences to detect all…
04 Aug 21
The new imaging software combines OCT with AI to provide physicians with an enhanced view of coronary blood…
The need for a development in blood tests for cancer diagnostics has led to a revelation in the…
06 Jul 21
The Exablate Neuro platform leverages Focused Ultrasound technology to ablate targets deep in the brain for therapeutic effect
29 Jun 21
Panbio Covid-19 Antigen Self-Test leverages Abbott lateral flow technology and is intended for use in adults and children…
09 Jun 21
The SARS-CoV-2 antigen self-test nasal enables users to share results and vaccine status on the company’s digital NAVIFY…